FDA Adverse Event Death Summary report: N

TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 1469913 · Received September 10, 2009

Report

Report Number
2134265-2009-04644
Event Type
Death
Date Received
September 10, 2009
Date of Event
February 1, 2006
Report Date
August 11, 2009
Manufacturer
BOSTON SCIENTIFIC
Product Code
NIQ
PMA / PMN Number
P030025
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVAL; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. THE BATCH # IS UNK AND THE MFG RECORDS FOR THE COMPLAINT DEVICE COULD NOT BE REVIEWED. THE ROOT CAUSE IS ANTICIPATED PROCEDURAL COMPLICATIONS AS THIS EVENT IS A KNOWN PHYSIOLOGICAL EFFECT OF THE PROCEDURE AND IS NOTED WITHIN THE DFU. LITERATURE CITATION: YA-LING H, XIAO-ZENG W, QUAN-MIN J, SHOU-LI W ET AL. COMPARISON OF RAPAMYCIN AND PACLITAXEL ELUTING STENT IN PTS WITH MULTI-VESSEL CORONARY DISEASE. CHINESE JOURNAL OF CARDIOLOGY 2006; 34: 123-130.

Description of Event or Problem · 1

IT WAS REPORTED IN THE JOURNAL ARTICLE TITLED: COMPARISON OF RAPAMYCIN AND PACLITAXEL ELUTING STENT IN PTS WITH MULTI-VESSEL CORONARY DISEASE, (ATTACHED) THAT POST CORONARY DRUG ELUTING STENTING TREATMENT PROCEDURE DEATH FROM HEART FAILURE OCCURRED. DURING THE INITIAL PROCEDURE AN UNSPECIFIED TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT WAS IMPLANTED. TARGET LESION LOCATION AND LESION CHARACTERISTICS WERE NOT PROVIDED. AT SOME POINT POST-PROCEDURE DEATH FROM HEART FAILURE OCCURRED. NO FURTHER INFO IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM NIQ STENT, CORONARY, DRUG-ELUTING NIQ BOSTON SCIENTIFIC

Patients

Seq Age Sex Outcome Treatment
1 Death